Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBIN K KELLEY

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1700805223
CMS profile
1180326
Location
LOS ANGELES, CA

General Payments · PY2018–2024

$66,141.99

  • Reported across 95 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$23,479.72

11 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $11,841.42 5
Moderna TX, Inc. $4,898.30 2
GlaxoSmithKline, LLC. $3,200.00 2
JAZZ PHARMACEUTICALS INC. $2,340.00 1
Coherus Biosciences Inc. $1,200.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,849.16 23
PY2019 $8,876.75 23
PY2020 $5,395.01 8
PY2021 $6,105.52 4
PY2022 $3,149.01 3
PY2023 $15,286.82 23
PY2024 $23,479.72 11

Payment records · PY2024 (11)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $110.79 02/08/2024 Food and Beverage Undisputed 01/23/2026 1105552902 CMS
AstraZeneca Pharmaceuticals LP $3,284.58 06/13/2024 Consulting Fee Undisputed 01/23/2026 1105843013 CMS
AstraZeneca Pharmaceuticals LP $1,876.90 06/14/2024 Consulting Fee Undisputed 01/23/2026 1104433105 CMS
AstraZeneca Pharmaceuticals LP $2,815.35 07/30/2024 Consulting Fee Undisputed 01/23/2026 1104308424 CMS
AstraZeneca Pharmaceuticals LP $3,753.80 08/08/2024 Consulting Fee Undisputed 01/23/2026 1105647644 CMS
Coherus Biosciences Inc. $1,200.00 06/18/2024 Honoraria Undisputed 01/23/2026 1147277452 CMS
GlaxoSmithKline, LLC. $1,600.00 03/22/2024 Consulting Fee Undisputed 01/23/2026 1116710113 CMS
GlaxoSmithKline, LLC. $1,600.00 06/06/2024 Consulting Fee Undisputed 01/23/2026 1116672006 CMS
JAZZ PHARMACEUTICALS INC. $2,340.00 06/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1150228419 CMS
ModernaTX, Inc. $98.30 01/19/2024 Food and Beverage Undisputed 01/23/2026 1152556165 CMS
ModernaTX, Inc. $4,800.00 04/25/2024 Consulting Fee Undisputed 01/23/2026 1152556345 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.